Literature DB >> 10553994

Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain.

S J Augood1, D M Martin, L J Ozelius, X O Breakefield, J B Penney, D G Standaert.   

Abstract

To gain insight into the neural pathways involved in the pathogenesis of DYT1 dystonia, we have mapped the cellular expression of the mRNA encoding torsinA and the closely related family member, torsinB, in normal adult human brain. Here, we report an intense expression of torsinA mRNA in the substantia nigra pars compacta dopamine neurons, the locus ceruleus, the cerebellar dentate nucleus, Purkinje cells, the basis pontis, numerous thalamic nuclei, the pedunculopontine nucleus, the oculomotor nucleus, the hippocampal formation, and the frontal cortex. Within the caudateputamen, the cellular expression of torsinA mRNA was heterogeneous; a moderate signal was found overlying large cholinergic neurons, and most striatal neurons exhibited only a very weak signal. A moderate signal was detected in numerous midbrain and hindbrain nuclei. A weak cellular signal was detected in neurons of the globus pallidus and subthalamic nucleus. In marked contrast to torsinA, no specific mRNA signal was detected for torsinB. That torsinA mRNA is enriched in several basal ganglia nuclei, including the dopamine neurons in the substantia nigra, is intriguing since it suggests that DYT1 dystonia may be associated with a dysfunction in dopamine transmission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553994

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  36 in total

1.  A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.

Authors:  N Sharma; J Hewett; L J Ozelius; V Ramesh; P J McLean; X O Breakefield; B T Hyman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.

Authors:  Sara B Mitchell; Sadahiro Iwabuchi; Hiroyuki Kawano; Tsun Ming Tom Yuen; Jin-Young Koh; K W David Ho; N Charles Harata
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 3.  Primary dystonia: molecules and mechanisms.

Authors:  Lauren M Tanabe; Connie E Kim; Noga Alagem; William T Dauer
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

4.  Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia.

Authors:  Chang-Hyun Song; Doug Bernhard; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

5.  Dysregulation of striatal dopamine release in a mouse model of dystonia.

Authors:  Li Bao; Jyoti C Patel; Ruth H Walker; Pullanipally Shashidharan; Margaret E Rice
Journal:  J Neurochem       Date:  2010-07-27       Impact factor: 5.372

6.  TorsinA restoration in a mouse model identifies a critical therapeutic window for DYT1 dystonia.

Authors:  Jay Li; Daniel S Levin; Audrey J Kim; Samuel S Pappas; William T Dauer
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

7.  Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out.

Authors:  Fumiaki Yokoi; Mai Tu Dang; Yuqing Li
Journal:  Behav Brain Res       Date:  2012-02-25       Impact factor: 3.332

Review 8.  Molecular pathways in dystonia.

Authors:  D Cristopher Bragg; Ioanna A Armata; Flavia C Nery; Xandra O Breakefield; Nutan Sharma
Journal:  Neurobiol Dis       Date:  2010-12-04       Impact factor: 5.996

9.  TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.

Authors:  Chun-Chi Liang; Lauren M Tanabe; Stephanie Jou; Frank Chi; William T Dauer
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

10.  Cerebellothalamocortical connectivity regulates penetrance in dystonia.

Authors:  Miklos Argyelan; Maren Carbon; Martin Niethammer; Aziz M Ulug; Henning U Voss; Susan B Bressman; Vijay Dhawan; David Eidelberg
Journal:  J Neurosci       Date:  2009-08-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.